NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 350 filers reported holding NATERA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,225,627 | -14.7% | 2,197,190 | -6.1% | 0.03% | -11.1% |
| Q2 2023 | $113,921,222 | -25.2% | 2,341,168 | -14.6% | 0.04% | -28.0% |
| Q1 2023 | $152,217,710 | +55.3% | 2,741,674 | +12.4% | 0.05% | +47.1% |
| Q4 2022 | $98,023,000 | +2.8% | 2,440,197 | +12.1% | 0.03% | -2.9% |
| Q3 2022 | $95,372,000 | +24.8% | 2,176,484 | +1.0% | 0.04% | +29.6% |
| Q2 2022 | $76,390,000 | +58.0% | 2,155,456 | +81.4% | 0.03% | +92.9% |
| Q1 2022 | $48,336,000 | -51.0% | 1,188,193 | +12.4% | 0.01% | -48.1% |
| Q4 2021 | $98,714,000 | -30.1% | 1,056,996 | -16.6% | 0.03% | -40.0% |
| Q3 2021 | $141,216,000 | -21.7% | 1,267,177 | -20.3% | 0.04% | -19.6% |
| Q2 2021 | $180,442,000 | -11.9% | 1,589,270 | -21.4% | 0.06% | -17.6% |
| Q1 2021 | $204,885,000 | +12.6% | 2,022,885 | +10.7% | 0.07% | +4.6% |
| Q4 2020 | $181,880,000 | +38.6% | 1,827,606 | +0.6% | 0.06% | +22.6% |
| Q3 2020 | $131,204,000 | +38.6% | 1,816,220 | -4.3% | 0.05% | +29.3% |
| Q2 2020 | $94,651,000 | +58.1% | 1,898,381 | -5.3% | 0.04% | +32.3% |
| Q1 2020 | $59,852,000 | +427.4% | 2,004,311 | +494.9% | 0.03% | +520.0% |
| Q4 2019 | $11,348,000 | +254.5% | 336,934 | +245.2% | 0.01% | +400.0% |
| Q3 2019 | $3,201,000 | +66.7% | 97,607 | +40.2% | 0.00% | 0.0% |
| Q2 2019 | $1,920,000 | +212.7% | 69,609 | +133.9% | 0.00% | – |
| Q1 2019 | $614,000 | -38.5% | 29,765 | -28.7% | 0.00% | – |
| Q3 2018 | $999,000 | -23.0% | 41,749 | -39.5% | 0.00% | -100.0% |
| Q2 2018 | $1,298,000 | -48.3% | 68,973 | -70.2% | 0.00% | -50.0% |
| Q3 2015 | $2,513,000 | – | 231,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |